GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of GLYC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in GlycoMimetics stock price on Friday which ended trading at $1.93
(Updated on Apr 19, 2024)

Sell candidate since Apr 03, 2024 Loss -30.38% PDF

The GlycoMimetics stock price fell by -10.88% on the last day (Friday, 19th Apr 2024) from $2.16 to $1.93. During the last trading day the stock fluctuated 15.43% from a day low at $1.88 to a day high of $2.17. The price has fallen in 7 of the last 10 days and is down by -30% for this period. Volume has increased on the last day by 287 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $2.24 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($2.19) are considered to be a "second chance" to get out. According to the fan-theory $1.43 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

GLYC Signals & Forecast

There are few to no technical positive signals at the moment. The GlycoMimetics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.24 and $2.70. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 27, 2024, and so far it has fallen -39.47%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for GlycoMimetics stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.290 between high and low, or 15.43%. For the last week, the stock has had daily average volatility of 11.03%.

GlycoMimetics is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GLYC) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect GlycoMimetics to open at $1.99, and during the day (based on 14 day Average True Range), to move between $1.70 and $2.15, which gives a possible trading interval of +/-$0.224 (+/-11.65%) up or down from last closing price. If GlycoMimetics takes out the full calculated possible swing range there will be an estimated 23.30% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $2.16, some $0.235 (12.21%) from the current price of $1.93, our system finds the risk reward not very attractive.

Is GlycoMimetics stock A Buy?

GlycoMimetics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.094 Strong Sell Candidate Unchanged

Predicted Opening Price for GlycoMimetics of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$1.99 ( 3.46%) $1.93

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for GLYC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.28 18.53 %
R2 2.17 12.77 %
R1 2.10 9.22 %
Current price: 1.93
Support S1 1.88 -2.29 %
S2 1.81 -5.85 %
S3 1.70 -11.60 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.28 18.44 %
R2 2.26 17.14 %
R1 2.16 12.21 %
Current price 1.93
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for GlycoMimetics Stock and on which exchange is it traded?
The symbol for GlycoMimetics is GLYC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell GlycoMimetics Stock?
GlycoMimetics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy GlycoMimetics Stock?
GlycoMimetics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy GlycoMimetics Stock.

What's the current price of GlycoMimetics Stock?
As of the end of day on the 2024-04-19, the price of an GlycoMimetics (GLYC) share was $1.93.

What is the 52-week high and low for GlycoMimetics Stock?
The 52-week high for GlycoMimetics Stock is $3.53 and the 52-week low is $1.11.

What is the market capitalization of GlycoMimetics Stock?
As of the 2024-04-19, the market capitalization of GlycoMimetics is 124.067M.

When is the next earnings date for GlycoMimetics?
The upcoming earnings date for GlycoMimetics is May 01, 2024.
Click to get the best stock tips daily for free!

About GlycoMimetics

GlycoMimetics GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as in phase 3 trial to treat relapsed/refractory AML. In addition, the company is developing G... GLYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT